Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma have?
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma has 641 citations in the OpenAlex counts ScholarIQ stores.
When was Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma published?
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma has 2021 year in the ScholarIQ index.
What is the open-access status of Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma?
Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma has hybrid oa status in the ScholarIQ index.
What is the DOI of Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma?
The DOI for Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma is on the source record.
What is the PMID of Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma?
The PMID for Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma is on the source record.
What is the OpenAlex record for Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma?
The OpenAlex for Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma is on the source record.